SOLARA ACTIVE PHARMA SCIENCES
Back to Income Statement
|
SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹-22 Cr | ₹-58 Cr | ₹221 Cr | ₹115 Cr | ₹60 Cr |
What is the latest Consolidated Net Profit of SOLARA ACTIVE PHARMA SCIENCES ?
Year | Consolidated Net Profit |
---|---|
Mar2023 | ₹-22 Cr |
Mar2022 | ₹-58 Cr |
Mar2021 | ₹221 Cr |
Mar2020 | ₹115 Cr |
Mar2019 | ₹60 Cr |
How is Consolidated Net Profit of SOLARA ACTIVE PHARMA SCIENCES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2023 | ₹-22 Cr | Negative | |
Mar2022 | ₹-58 Cr | Negative | |
Mar2021 | ₹221 Cr | 93.18 | |
Mar2020 | ₹115 Cr | 92.59 | |
Mar2019 | ₹60 Cr | - |
Compare Consolidated Net Profit of peers of SOLARA ACTIVE PHARMA SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SOLARA ACTIVE PHARMA SCIENCES | ₹1,989.5 Cr | 2% | 40.1% | 42.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SOLARA ACTIVE PHARMA SCIENCES | 2% |
40.1% |
42.2% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses